Partners & Investors

Opimend is actively interested in strategic partnerships with non-profit organizations, companies, researchers and investors that complement Opimend’s development plans.


Investigators and institutions interested in conducting investigator-initiated pre-clinical and clinical trials with our proprietary formulations.


Early asset licensing at individual country or regional level.


Co-development agreements with pharma/biotech companies interested in solutions for the opioid crisis.


Non-profit organizations, private and institutional investors interested in investing in our promising technologies.

To inquire about partnering/investment opportunities with Opimend, please send an email to our business development team: